Ovarian cancer is not a single disease and can be subdivided into at least five different
histological subtypes that have different identifiable risk factors, cells of origin, molecular …

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of
Adult Cancers: American Society of Clini Page 1 Prevention and Management of …

Importance There are no known effective treatments for painful chemotherapy-induced
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Carfilzomib is a next-generation, selective proteasome inhibitor being evaluated for the
treatment of relapsed and refractory multiple myeloma. In this open-label, single-arm phase …

Background The objective of this study was to systematically review all available literature
concerning chemotherapy-induced peripheral neuropathy (CIPN) and quality of life (QOL) …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Abstract The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement
System is a collection of health-related quality of life (HRQOL) questionnaires targeted to the …

Commonly used chemotherapeutic agents in oncology/hematology practice, causing toxic
peripheral neuropathy, include taxanes, platinum compounds, vinca alkaloids, proteasome …

Background There are inconsistencies in the literature regarding the prevalence and
assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored …